M 318 (Pioglitazone Hydrochloride 45 mg (base))
Pill with imprint M 318 is White, Round and has been identified as Pioglitazone Hydrochloride 45 mg (base). It is supplied by Mylan Pharmaceuticals Inc..
Pioglitazone is used in the treatment of diabetes, type 2; nonalcoholic fatty liver disease and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Pioglitazone 45 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 318
Pioglitazone Hydrochloride
- Imprint:
- M 318
- Strength:
- 45 mg (base)
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Thiazolidinediones
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 51079-0515 | UDL Laboratories Inc. |
More about pioglitazone
- Pioglitazone Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 36 Reviews
- Drug class: thiazolidinediones
- FDA Alerts (4)
Consumer resources
Other brands: Actos
Professional resources
- Pioglitazone Hydrochloride (AHFS Monograph)
- Pioglitazone Tablets (FDA)
- Pioglitazone (Wolters Kluwer)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
